ATE475434T1 - Hämostatische sprays und zusammensetzungen - Google Patents

Hämostatische sprays und zusammensetzungen

Info

Publication number
ATE475434T1
ATE475434T1 AT05700613T AT05700613T ATE475434T1 AT E475434 T1 ATE475434 T1 AT E475434T1 AT 05700613 T AT05700613 T AT 05700613T AT 05700613 T AT05700613 T AT 05700613T AT E475434 T1 ATE475434 T1 AT E475434T1
Authority
AT
Austria
Prior art keywords
hemostatic
sprays
compositions
hemostatic sprays
Prior art date
Application number
AT05700613T
Other languages
English (en)
Inventor
Fisker Lene Moller
Original Assignee
Ferrosan As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrosan As filed Critical Ferrosan As
Application granted granted Critical
Publication of ATE475434T1 publication Critical patent/ATE475434T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/06—Ampoules or carpules
    • A61J1/067—Flexible ampoules, the contents of which are expelled by squeezing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/363—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4833—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A61L15/325—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D1/00—Rigid or semi-rigid containers having bodies formed in one piece, e.g. by casting metallic material, by moulding plastics, by blowing vitreous material, by throwing ceramic material, by moulding pulped fibrous material or by deep-drawing operations performed on sheet material
    • B65D1/32—Containers adapted to be temporarily deformed by external pressure to expel contents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D83/00—Containers or packages with special means for dispensing contents
    • B65D83/06—Containers or packages with special means for dispensing contents for dispensing powdered or granular material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Mechanical Engineering (AREA)
  • Biomedical Technology (AREA)
  • Materials Engineering (AREA)
  • Ceramic Engineering (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT05700613T 2004-01-30 2005-01-28 Hämostatische sprays und zusammensetzungen ATE475434T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US54000504P 2004-01-30 2004-01-30
US54697204P 2004-02-24 2004-02-24
PCT/DK2005/000063 WO2005072700A2 (en) 2004-01-30 2005-01-28 Haemostatic sprays and compositions

Publications (1)

Publication Number Publication Date
ATE475434T1 true ATE475434T1 (de) 2010-08-15

Family

ID=34830497

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05700613T ATE475434T1 (de) 2004-01-30 2005-01-28 Hämostatische sprays und zusammensetzungen

Country Status (10)

Country Link
US (1) US7923031B2 (de)
EP (1) EP1713521B1 (de)
JP (1) JP2007519450A (de)
CN (1) CN1921896B (de)
AR (1) AR054637A1 (de)
AT (1) ATE475434T1 (de)
CA (1) CA2554994C (de)
DE (1) DE602005022554D1 (de)
RU (1) RU2377022C9 (de)
WO (1) WO2005072700A2 (de)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7927626B2 (en) 2003-08-07 2011-04-19 Ethicon, Inc. Process of making flowable hemostatic compositions and devices containing such compositions
CN101001649B (zh) * 2004-07-09 2011-08-31 弗罗桑医疗设备公司 包括透明质酸的止血组合物及其制备方法
FR2881651A1 (fr) * 2005-02-09 2006-08-11 Urodelia Sa Nouveau produit pharmaceutique et procede de fabrication de ce produit pharmaceutique
DK2004214T3 (da) * 2006-03-16 2013-02-18 Stellaris Pharmaceuticals Aps Lokalbehandling med faktor VII
US20080004431A1 (en) * 2006-06-30 2008-01-03 Warsaw Orthopedic Inc Method of manufacturing an injectable collagen material
CN102014973A (zh) 2008-02-29 2011-04-13 弗罗桑医疗设备公司 用于促进止血和/或伤口愈合的装置
DE102008015961A1 (de) 2008-03-20 2009-09-24 Gelita Ag Verwendung von Gelatinepartikeln in Pulverbeschichtungsverfahren
PT2373373E (pt) 2008-12-15 2014-03-04 Profibrix Bv Dispositivo de distribuição de pó
EP2332438A1 (de) * 2009-12-14 2011-06-15 KPSS-Kao Professional Salon Services GmbH Düse zum Aufbringen eines Pulvers
MX344402B (es) 2010-06-01 2016-12-14 Baxter Int Inc * Proceso para elaborar composiciones hemostaticas secas y estables.
CN101857095B (zh) * 2010-06-13 2012-04-04 林虎强 一种用石墨粉润滑的方法
MD4163C1 (ro) * 2010-12-23 2012-11-30 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Preparat medicamentos sub formă de gel pentru profilaxia complicaţiilor postoperatorii
GB201021881D0 (en) 2010-12-23 2011-02-02 Profibrix Bv Powder delivery device
US9447169B2 (en) * 2011-03-04 2016-09-20 Orthovita, Inc. Flowable collagen-based hemostat and methods of use
PL2626092T3 (pl) * 2011-04-01 2016-02-29 Zhuhai Ortus Biotechnology Co Ltd Medyczny wchłanialny hemostatyczny materiał do ran z obnażeniem kości i sposób jego wytwarzania
EP2701729B1 (de) * 2011-04-27 2019-05-22 Biom'up Hämostatische zusammensetzung
RS54247B1 (sr) 2011-04-27 2016-02-29 Biom'up Rasprašivač za biomedicinski hemostatski prašak
US20130202675A1 (en) * 2012-02-03 2013-08-08 Dynasil Biomedical Corporation Systems and methods for the fabrication of tissue patches
WO2013131520A2 (en) 2012-03-06 2013-09-12 Ferrosan Medical Devices A/S Pressurized container containing haemostatic paste
US8815832B2 (en) 2012-05-25 2014-08-26 Ethicon, Inc. Oxidized regenerated cellulose hemostatic powders and methods of making
RU2636240C2 (ru) * 2012-06-12 2017-11-21 Ферросан Медикал Дивайсиз А/С Сухая гемостатическая композиция
US10016527B2 (en) 2012-10-23 2018-07-10 Orthovita, Inc. Materials and methods for repair of cartilage defects
US20140200548A1 (en) * 2013-01-17 2014-07-17 Merit Medical Systems, Inc. Apparatuses and kits for grinding or cutting surgical foam and methods related thereto
US11433254B2 (en) * 2013-03-15 2022-09-06 Pavel V. Efremkin Apparatus and method for treatment of wounds and skin medical conditions at a predetermined skin area
EP2997077B1 (de) * 2013-05-15 2018-11-07 EURORESEARCH S.r.L. Kollagenpuder und deren anwendung
WO2014195248A1 (en) * 2013-06-03 2014-12-11 Essentra Filter Products Development Co. Pte. Ltd Dispenser, and method of manufacture thereof
EP3010419B1 (de) 2013-06-21 2020-05-20 Ferrosan Medical Devices A/S Vakuumerweiterte trockenzusammensetzung und spritze zum zurückhalten davon
US10342891B2 (en) * 2013-09-19 2019-07-09 Medline Industries, Inc. Wound dressing containing saccharide and collagen
JP6489485B2 (ja) 2013-12-11 2019-03-27 フェロサン メディカル デバイシーズ エイ／エス 押し出し増強因子を含んでいる乾燥組成物
KR101864465B1 (ko) 2014-01-21 2018-06-04 재단법인 유타 인하 디디에스 및 신의료기술개발 공동연구소 의료용 도관을 통한 생체 내 투여성 마이크로 입자
US10183132B2 (en) 2014-09-11 2019-01-22 Ethicon Llc Methods and devices for co-delivery of liquid and powdered hemostats and sealants
CA2960309A1 (en) 2014-10-13 2016-04-21 Ferrosan Medical Devices A/S Dry composition for use in haemostasis and wound healing
RU2705905C2 (ru) 2014-12-24 2019-11-12 Ферросан Медикал Дивайсиз А/С Шприц для удерживания и смешивания первого и второго веществ
US10507293B2 (en) 2015-06-24 2019-12-17 Ethicon, Inc. Hemostatic powder delivery devices and methods
KR101699924B1 (ko) * 2015-06-26 2017-01-25 한국생산기술연구원 칼슘 카르복시메틸 셀룰로오스 및 키토산 화합물을 포함하는 의료용 섬유 구조체 및 그의 제조 방법
AU2016290433B2 (en) 2015-07-03 2018-05-24 Ferrosan Medical Devices A/S Syringe for mixing two components and for retaining a vacuum in a storage condition
EP3320925B1 (de) * 2015-07-10 2024-02-28 FUJIFILM Corporation Zellstruktur und verfahren zur herstellung der zellstruktur
WO2017027378A1 (en) 2015-08-07 2017-02-16 Xcede Technologies, Inc. Adhesive compositions and related methods
US9833538B2 (en) 2015-08-07 2017-12-05 Xcede Technologies, Inc. Adhesive compositions and related methods
US9540548B1 (en) 2015-08-07 2017-01-10 Xcede Technologies, Inc. Adhesive compositions and related methods
CN105126152B (zh) * 2015-10-07 2018-01-16 中国海洋大学 一种明胶壳聚糖复合止血粉
KR102708805B1 (ko) 2015-11-08 2024-09-25 에디컨인코포레이티드 지혈 조성물
CN105597144A (zh) * 2015-12-31 2016-05-25 北京湃生生物科技有限公司 一种可吸收胶原止血粉及其制备方法
CN105688269B (zh) * 2016-02-03 2021-04-16 广州迈普再生医学科技股份有限公司 一种改性明胶止血材料及其制备方法
CN106178204B (zh) * 2016-07-11 2019-05-10 赵彧 一种喷洒粉剂止血药物肠镜用导管
US11052172B2 (en) 2016-08-12 2021-07-06 Biom'up France SAS Hemostatic flowable
TWI674903B (zh) * 2016-09-26 2019-10-21 國立陽明大學 製備改良豬血漿纖連蛋白以增強傷口癒合之應用
CN106421871A (zh) * 2016-09-29 2017-02-22 广州赛莱拉干细胞科技股份有限公司 一种喷雾型医用胶原贴敷料及其制备方法
IL249725A0 (en) * 2016-12-22 2017-03-30 Omrix Biopharmaceuticals Ltd A hemostatic preparation containing an anion exchanger and a calcium salt
EP3568179B1 (de) 2017-01-10 2021-10-27 Boston Scientific Scimed, Inc. Vorrichtungen zur abgabe von pulverförmigen wirkstoffen
US11679177B2 (en) 2017-08-08 2023-06-20 Baxter International Inc. Polymeric compositions, delivery devices, and methods
SG11202001547RA (en) * 2017-09-12 2020-03-30 Shilpa Medicare Ltd Tranexamic acid spray for knee arthroplasty
WO2019089787A1 (en) * 2017-11-03 2019-05-09 Baxter International Inc. Polymeric compositions, delivery devices, and methods
CN108261604A (zh) * 2017-12-07 2018-07-10 上海昊海生物科技股份有限公司 用于伤口护理、创面封闭的无菌粉末喷涂装置
CA3090405A1 (en) 2018-02-15 2019-08-22 Biom'up France SAS Multi-dimensional hemostatic product and method for producing the same
US10543499B1 (en) * 2018-03-13 2020-01-28 Karriem Cherry Disposable powder-dispensing bulb
ES2968412T3 (es) 2018-05-09 2024-05-09 Ferrosan Medical Devices As Método para preparar una composición hemostática
WO2021014357A1 (en) * 2019-07-23 2021-01-28 Kci Licensing, Inc. Collagen-based biomaterials for wound management
US20220323549A1 (en) * 2019-09-12 2022-10-13 Global Health Solutions, Inc. Oil-based wound care compositions and methods
CN112516377B (zh) * 2020-11-23 2022-05-27 铨丰科技(深圳)有限公司 一种胶原微纤维止血材料及其制备方法和使用方法
JP7504545B2 (ja) * 2020-12-24 2024-06-24 株式会社吉野工業所 注出容器
CN113017899B (zh) * 2021-03-03 2022-07-08 兆丰华生物科技(福州)有限公司 一种高效的大兔接种方法
CN118284367A (zh) 2021-09-10 2024-07-02 广州倍绣生物技术有限公司 用于在手术部位控制出血并密封组织的组合式止血粉末和液体递送装置
US12220118B2 (en) 2022-03-31 2025-02-11 Ethicon, Inc. Systems, devices and methods for reconstituting therapeutic powders, mixing precursor solutions, and expressing sealants for controlling bleeding and sealing fluid and air leaks
US12114843B2 (en) 2022-03-31 2024-10-15 Ethicon, Inc. Sealant applicators having mixing and spraying assemblies with malleable sections and spray tips having reduced dimensions
CN115364273A (zh) * 2022-09-17 2022-11-22 中国人民解放军空军军医大学 一种可喷雾纳米氧化纤维素止血凝胶的制备方法
CN120751989A (zh) 2023-03-09 2025-10-03 生化学工业株式会社 给药装置及医疗用具

Family Cites Families (184)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2465357A (en) * 1944-08-14 1949-03-29 Upjohn Co Therapeutic sponge and method of making
US2465860A (en) * 1945-10-13 1949-03-29 Standard Manifold Company Inc Carbon holder
GB648619A (en) 1947-03-19 1951-01-10 Ferrosan As Process of producing sponges of gelatine and the like proteins
CH264752A (de) * 1947-06-03 1949-10-31 Hoffmann La Roche Verfahren zur Herstellung von Trägern für Arzneimittel.
GB697603A (en) 1948-10-06 1953-09-23 Sydney Arthur Gladstone Improvements in or relating to method of and devices for obtaining tissue from a tumour carried by a patient
US3224434A (en) 1962-11-06 1965-12-21 Waldemar Medical Res Foundatio Cell collector
US3869539A (en) * 1966-12-01 1975-03-04 Ferrosan As Preparations containing fat-soluble vitamins in dry, particulate, free-flowing form dispersible in cold water and method of producing such preparations
US3678933A (en) * 1970-07-17 1972-07-25 Moore Perk Corp Surgical sponge or bandage
FR2167197B1 (fr) 1972-01-10 1974-06-21 Pont Brule Sa Compositions ameliorees contenant de la gelatine
US3815580A (en) * 1972-08-31 1974-06-11 C Oster Apparatus for and method of collecting and preserving cytologic samples
US4280954A (en) * 1975-07-15 1981-07-28 Massachusetts Institute Of Technology Crosslinked collagen-mucopolysaccharide composite materials
US4098728A (en) * 1976-01-02 1978-07-04 Solomon Rosenblatt Medical surgical sponge and method of making same
GB1584080A (en) 1977-12-05 1981-02-04 Ethicon Inc Absorbable hemostatic composition
US4265233A (en) * 1978-04-12 1981-05-05 Unitika Ltd. Material for wound healing
DE2943520C2 (de) * 1979-10-27 1982-05-19 Fa. Carl Freudenberg, 6940 Weinheim Verfahren zur Herstellung von Kollagenschwamm für medizinische oder kosmetische Zwecke
DE3146841A1 (de) 1981-11-26 1983-06-01 Beiersdorf Ag, 2000 Hamburg "neue wundbehandlungsmittel"
JPS5928472A (ja) 1982-08-09 1984-02-15 Koken:Kk 細胞培養用基質およびこの基質を用いた細胞培養・分離法
US4492305A (en) * 1983-07-08 1985-01-08 Marion Laboratories, Inc. Package for collecting cultures
US4515637A (en) * 1983-11-16 1985-05-07 Seton Company Collagen-thrombin compositions
US4522302A (en) * 1984-03-05 1985-06-11 Sterling Drug Inc. Pre-sterilized medical procedure kit packages
ZA851661B (en) 1984-03-29 1986-10-29 Minnesota Mining & Mfg Sorbent sheet material
JPS6144825A (ja) * 1984-08-09 1986-03-04 Unitika Ltd 止血剤
JPS61122222A (ja) * 1984-11-19 1986-06-10 Koken:Kk コラ−ゲン又はゼラチンとプロタミンとよりなる止血剤
JPS61209590A (ja) * 1985-03-13 1986-09-17 Asama Kasei Kk 新規な固定化細胞およびそれを利用する醗酵生産法
US4861714A (en) * 1985-04-04 1989-08-29 Verax Corporation Weighted collagen microsponge for immobilizing bioactive material
US4997753A (en) * 1985-04-04 1991-03-05 Verax Corporation Weighted collagen microsponge for immobilizing bioactive material
US4863856A (en) 1985-04-04 1989-09-05 Verax Corporation Weighted collagen microsponge for immobilizing bioactive materials
AT382783B (de) * 1985-06-20 1987-04-10 Immuno Ag Vorrichtung zur applikation eines gewebeklebstoffes
US5112750A (en) * 1985-06-25 1992-05-12 Asama Chemical Co., Ltd. Immobilized cells and culture method utilizing the same
US4851521A (en) * 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
US4696812A (en) 1985-10-28 1987-09-29 Warner-Lambert Company Thrombin preparations
US5180583A (en) * 1985-11-26 1993-01-19 Hedner Ulla K E Method for the treatment of bleeding disorders
US20020192271A1 (en) 1985-11-26 2002-12-19 Hedner Ulla Karin Elisabeth Method for causing local hemostasis and hemostatic composition for local hemostasis
US5690954A (en) 1987-05-22 1997-11-25 Danbiosyst Uk Limited Enhanced uptake drug delivery system having microspheres containing an active drug and a bioavailability improving material
JPS6485653A (en) 1987-09-28 1989-03-30 Terumo Corp Drug receiving container
JPH01130519A (ja) * 1987-11-16 1989-05-23 Mitsubishi Electric Corp Ｍｏｃｖｄ結晶成長装置
US5024841A (en) * 1988-06-30 1991-06-18 Collagen Corporation Collagen wound healing matrices and process for their production
EP0365705A1 (de) 1988-10-26 1990-05-02 Zentralna Problemna Laboratoria Po Kryobiologia I Lyophilisazia Biopräparat zur Behandlung von Wunden
US4891359A (en) * 1988-12-08 1990-01-02 Johnson & Johnson Patient Care, Inc. Hemostatic collagen paste composition
US5356883A (en) 1989-08-01 1994-10-18 Research Foundation Of State University Of N.Y. Water-insoluble derivatives of hyaluronic acid and their methods of preparation and use
US5196185A (en) * 1989-09-11 1993-03-23 Micro-Collagen Pharmaceutics, Ltd. Collagen-based wound dressing and method for applying same
US4982769A (en) * 1990-02-21 1991-01-08 Survival Technology, Inc. Package
JPH0813750B2 (ja) 1990-03-01 1996-02-14 持田製薬株式会社 経口用トロンビン製剤
US5595735A (en) * 1990-05-23 1997-01-21 Johnson & Johnson Medical, Inc. Hemostatic thrombin paste composition
EP0478827B1 (de) 1990-10-04 1994-04-06 Kallies Import-Export Vertrieb Gmbh Stabilisiertes Thrombin, seine Herstellung und seine Verwendung als Thrombinzeitreagens
US5669934A (en) 1991-02-13 1997-09-23 Fusion Medical Technologies, Inc. Methods for joining tissue by applying radiofrequency energy to performed collagen films and sheets
US5749895A (en) * 1991-02-13 1998-05-12 Fusion Medical Technologies, Inc. Method for bonding or fusion of biological tissue and material
EP0572526A4 (en) 1991-02-13 1995-12-06 Interface Biomedical Lab Corp Filler material for use in tissue welding
US5690675A (en) 1991-02-13 1997-11-25 Fusion Medical Technologies, Inc. Methods for sealing of staples and other fasteners in tissue
JP3407072B2 (ja) * 1991-02-14 2003-05-19 バクスター、インターナショナル、インコーポレイテッド リポソームへの認識物質の結合
DE4119140C2 (de) 1991-06-11 1994-05-11 Merz & Co Gmbh & Co Poröser, in Körperflüssigkeiten und Sekreten löslicher, spongoider Formkörper, dessen Herstellung und Verwendung
FR2679772B1 (fr) 1991-08-02 1995-05-19 Peters Sa Emboles en particules non resorbables enrobees de materiau hemostatique.
IT1251151B (it) * 1991-08-05 1995-05-04 Fidia Spa Materiale spugnoso essenzialmente costituito da acido ialuronico,o suoi derivati
US6620436B1 (en) 1991-10-09 2003-09-16 Lectec Corporation Mixing and dispensing package for a wound dressing
GB2266239B (en) 1992-03-25 1996-03-06 Jevco Ltd Wound healing compositions containing chondroitin sulphate oligosaccharides
GB9206509D0 (en) 1992-03-25 1992-05-06 Jevco Ltd Heteromorphic sponges containing active agents
IL105529A0 (en) * 1992-05-01 1993-08-18 Amgen Inc Collagen-containing sponges as drug delivery for proteins
US5547376A (en) * 1992-06-18 1996-08-20 Harrel; Stephen K. Methods and apparatus for containing and recovering abrasive powders from an abrasive polisher
US5443481A (en) * 1992-07-27 1995-08-22 Lee; Benjamin I. Methods and device for percutaneous sealing of arterial puncture sites
WO1994006460A1 (en) 1992-09-21 1994-03-31 Vitaphore Corporation Embolization plugs for blood vessels
DE69322789T2 (de) * 1992-10-19 1999-07-01 Dura Pharmaceuticals, Inc., San Diego, Calif. Trockenpulverinhalator
US5334216A (en) 1992-12-10 1994-08-02 Howmedica Inc. Hemostatic plug
JP2950520B2 (ja) * 1993-04-02 1999-09-20 アンティキャンサー インコーポレーテド 毛胞に有益な配合物を送達する方法
US5951531A (en) 1993-04-20 1999-09-14 Medchem Products, Inc. Apparatus and method for applying a particulate hemostatic agent to living tissue
US5723308A (en) * 1993-05-14 1998-03-03 Minnesota Mining And Manufacturing Company Culture medium for rapid count of coliform bacteria
US5951583A (en) 1993-05-25 1999-09-14 Vascular Solutions, Inc. Thrombin and collagen procoagulant and process for making the same
US5387208A (en) * 1993-07-26 1995-02-07 The Procter & Gamble Co. Absorbent core having improved dry/wet integrity
US5798091A (en) 1993-07-30 1998-08-25 Alliance Pharmaceutical Corp. Stabilized gas emulsion containing phospholipid for ultrasound contrast enhancement
US5394886A (en) * 1993-09-20 1995-03-07 Nabai; Hossein Skin biopsy plug and method
ATE273035T1 (de) * 1993-11-03 2004-08-15 Clarion Pharmaceuticals Inc Hämostatisches pflaster
SG47996A1 (en) * 1993-12-30 1998-04-17 Nitta Gelatin Kk Method for culturing animal cells under embedded conditions
DE4407875C2 (de) 1994-03-04 1996-04-04 Ankerpharm Gmbh Ankerwerk Rudo Medizinischer Schwamm aus biologisch resorbierbaren Materialien, Verfahren und Vorrichtung zu dessen Herstellung
ITPD940054A1 (it) * 1994-03-23 1995-09-23 Fidia Advanced Biopolymers Srl Polisaccaridi solfatati
CA2146090C (en) 1994-05-10 1998-11-24 Mark E. Mitchell Apparatus and method of mixing materials in a sterile environment
US5462860A (en) 1994-06-06 1995-10-31 Minnesota Mining And Manufacturing Company Conditioned culture medium for rapid growth and detection of microbes
US5931165A (en) 1994-09-06 1999-08-03 Fusion Medical Technologies, Inc. Films having improved characteristics and methods for their preparation and use
JP2858087B2 (ja) 1994-09-19 1999-02-17 グンゼ株式会社 組織培養用基材及び組織培養法
FR2726571B1 (fr) 1994-11-03 1997-08-08 Izoret Georges Colle biologique, procede de preparation et dispositif d'application pour colle biologique, et durcisseurs pour colle biologique
US5660854A (en) * 1994-11-28 1997-08-26 Haynes; Duncan H Drug releasing surgical implant or dressing material
US6074663A (en) * 1995-01-16 2000-06-13 Baxter International Inc. Method of using cross-linked fibrin material
DE19513666C1 (de) * 1995-04-11 1996-11-28 Behringwerke Ag Vorrichtung zum Zusammenführen einer ersten flüssigen und einer zweiten festen oder flüssigen Komponente mittels Unterdruck unter sterilen Bedingungen
JP3799626B2 (ja) 1995-04-25 2006-07-19 有限会社ナイセム 心臓血管修復材及びその製造方法
DE19521324C1 (de) * 1995-06-12 1996-10-31 Immuno Ag Gewebeklebstoff und Verwendung desselben als Hämostyptikum
AU7398196A (en) * 1995-10-11 1997-04-30 Fusion Medical Technologies, Inc. Device and method for sealing tissue
HUP9903586A3 (en) 1996-04-04 2003-02-28 Baxter Ag Hemostatic sponge based on collagen
US5948427A (en) * 1996-04-25 1999-09-07 Point Medical Corporation Microparticulate surgical adhesive
US5791352A (en) * 1996-06-19 1998-08-11 Fusion Medical Technologies, Inc. Methods and compositions for inhibiting tissue adhesion
AR013829A1 (es) 1996-07-12 2001-01-31 Baxter Int Un dispositivo medico para suministrar cantidades volumetricas de un primer y un segundo fluido, bioquimicamente reactivos, y metodo para suministrarfibrina a una superficie con dicho dispositivo
US7320962B2 (en) 1996-08-27 2008-01-22 Baxter International Inc. Hemoactive compositions and methods for their manufacture and use
US6706690B2 (en) * 1999-06-10 2004-03-16 Baxter Healthcare Corporation Hemoactive compositions and methods for their manufacture and use
US7435425B2 (en) * 2001-07-17 2008-10-14 Baxter International, Inc. Dry hemostatic compositions and methods for their preparation
US6066325A (en) 1996-08-27 2000-05-23 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
US6063061A (en) * 1996-08-27 2000-05-16 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
CA2211629A1 (en) * 1996-09-17 1998-03-17 Bernard Sams Vial connector assembly for a medicament container
US5795330A (en) 1996-10-10 1998-08-18 Etex Corporation Mixing device
US5743412A (en) * 1996-11-13 1998-04-28 Chrysler Corporation Modular parts supply rack
US5782860A (en) 1997-02-11 1998-07-21 Biointerventional Corporation Closure device for percutaneous occlusion of puncture sites and tracts in the human body and method
US6045570A (en) * 1997-02-11 2000-04-04 Biointerventional Corporation Biological sealant mixture and system for use in percutaneous occlusion of puncture sites and tracts in the human body and method
US5905029A (en) * 1997-02-19 1999-05-18 Fritz Berthold Method for rapid hygiene testing
FR2759980A1 (fr) 1997-02-25 1998-08-28 Bras Michel Conditionnement de deux substances destinees a etre melangees
US5939259A (en) 1997-04-09 1999-08-17 Schleicher & Schuell, Inc. Methods and devices for collecting and storing clinical samples for genetic analysis
US6716435B1 (en) * 1997-04-18 2004-04-06 Ganeden Biotech, Inc. Absorbent product containing absorbent structure and Bacillus coagulans
US20020039594A1 (en) * 1997-05-13 2002-04-04 Evan C. Unger Solid porous matrices and methods of making and using the same
US5908054A (en) * 1997-06-16 1999-06-01 Fusion Medical Technologies, Inc. Fluid dispersion and delivery assembly and method
US5957166A (en) 1997-06-16 1999-09-28 Fusion Medical Technologies, Inc. Method and apparatus for dispersing fluid into a material
WO1998057678A2 (en) 1997-06-18 1998-12-23 Cohesion Technologies, Inc. Compositions containing thrombin and microfibrillar collagen
US6042262A (en) * 1997-07-29 2000-03-28 Stryker Technologies Corportion Apparatus for storing, mixing, and dispensing two-component bone cement
US6162241A (en) 1997-08-06 2000-12-19 Focal, Inc. Hemostatic tissue sealants
WO1999010385A1 (en) * 1997-08-22 1999-03-04 Denki Kagaku Kogyo Kabushiki Kaisha Hyaluronic acid gel, process for producing the same and medical material containing the same
US6168788B1 (en) * 1997-09-26 2001-01-02 Leon Wortham Fibrin glue without fibrinogen and biosealant compositions and methods
GB2329840C (en) * 1997-10-03 2007-10-05 Johnson & Johnson Medical Biopolymer sponge tubes
US6303323B1 (en) 1997-10-21 2001-10-16 Cancer Research Campaign Technology Limited Detection of dysplastic or neoplastic cells using anti-MCM5 antibodies
JP3483753B2 (ja) 1997-12-29 2004-01-06 タキロン株式会社 生体内分解吸収性可塑性粘着物
US6099952A (en) 1998-02-18 2000-08-08 Xomed Surgical Products, Inc. Medical sponge having mucopolysaccharide coating
ATE371472T1 (de) 1998-03-06 2007-09-15 Baxter Int Turbulenz-mischkopf für gewebeklebstoff- applikator und sprühkopf für selbigen
US20020025921A1 (en) * 1999-07-26 2002-02-28 Petito George D. Composition and method for growing, protecting, and healing tissues and cells
US20020061842A1 (en) * 1998-04-10 2002-05-23 Octapharma Ag Method for sterilizing a native collagen in liquid medium, sterile native collagen obtained, compositions containing it and uses
FR2777284B1 (fr) * 1998-04-10 2000-05-26 Hamza Mansour Procede de sterilisation d'un collagene natif en milieu liquide, collagene natif sterile obtenu, compositions le contenant et applications
US6200328B1 (en) 1998-05-01 2001-03-13 Sub Q, Incorporated Device and method for facilitating hemostasis of a biopsy tract
ITPD980169A1 (it) 1998-07-06 2000-01-06 Fidia Advanced Biopolymers Srl Ammidi dell'acido ialuronico e dei suoi derivati e processo per la loro preparazione.
JP2003521270A (ja) * 1998-08-04 2003-07-15 フュージョン メディカル テクノロジーズ， インコーポレイテッド 経皮組織路閉塞アセンブリおよび方法
US6613070B2 (en) * 1998-08-04 2003-09-02 Baxter International Inc. System and method for sealing vascular penetrations with hemostatic gels
US6334865B1 (en) * 1998-08-04 2002-01-01 Fusion Medical Technologies, Inc. Percutaneous tissue track closure assembly and method
US20020015724A1 (en) * 1998-08-10 2002-02-07 Chunlin Yang Collagen type i and type iii hemostatic compositions for use as a vascular sealant and wound dressing
US6454787B1 (en) 1998-12-11 2002-09-24 C. R. Bard, Inc. Collagen hemostatic foam
US6283933B1 (en) 1998-12-23 2001-09-04 Closure Medical Corporation Applicator for dispensable liquids
KR100804434B1 (ko) 1998-12-23 2008-02-20 체에스엘 베링 게엠베하 피브린계 접착제 과립 및 이의 제조방법
US6977231B1 (en) 1999-01-21 2005-12-20 Nipro Corporation Suturable adhesion-preventing membrane
US6862470B2 (en) 1999-02-02 2005-03-01 Senorx, Inc. Cavity-filling biopsy site markers
CA2371833C (en) 1999-02-19 2009-09-15 Denki Kagaku Kogyo Kabushiki Kaisha Hyaluronic acid gel composition, process for its production and medical material containing it
US6312725B1 (en) 1999-04-16 2001-11-06 Cohesion Technologies, Inc. Rapid gelling biocompatible polymer composition
EP1053758A1 (de) 1999-05-19 2000-11-22 Resorba Chirurgisches Nahtmaterial Franz Hiltner GmbH & Co. Bioabsorbierbares Implantat
US20020019062A1 (en) * 1999-06-18 2002-02-14 Peter Lea Assay devices
ES2383122T3 (es) 1999-08-27 2012-06-18 Angiodevice International Gmbh Dispositivo de polímero biocompatible
US20030095993A1 (en) * 2000-01-28 2003-05-22 Hanne Bentz Gel-infused sponges for tissue repair and augmentation
IT1317832B1 (it) * 2000-02-15 2003-07-15 Eurores S R L Procedimento per la preparazione di collagene micronizzato e sueapplicazioni terapeutiche.
EP1286707A2 (de) 2000-02-18 2003-03-05 Regeneration Technologies, Inc. Mit wachstumsfaktoren und weiteren zusätzen imprägniertes implantierbares gewebe
EP1149906A1 (de) 2000-04-25 2001-10-31 Pliva, Farmaceutska, Industrija, Dionicko Drustvo Thrombopoietin Rezeptormodulations Peptide
US20020010150A1 (en) * 2000-04-28 2002-01-24 Cortese Stephanie M. Homostatic compositions of polyacids and polyalkylene oxides and methods for their use
AT412445B (de) * 2000-06-20 2005-03-25 Biering Wolfgang Flüssiges collagen-hämostatikum
JP2004504330A (ja) * 2000-07-13 2004-02-12 インヴィトロジェン　コーポレーション 溶解マトリクスを用いてタンパク質およびペプチドの迅速な抽出および単離のための方法および組成物
US20030032143A1 (en) * 2000-07-24 2003-02-13 Neff Thomas B. Collagen type I and type III compositions for use as an adhesive and sealant
WO2002009792A1 (en) * 2000-07-28 2002-02-07 Anika Therapeutics, Inc. Bioabsorbable composites of derivatized hyaluronic acid
US6890342B2 (en) * 2000-08-02 2005-05-10 Loma Linda University Method and apparatus for closing vascular puncture using hemostatic material
JP2002060341A (ja) * 2000-08-21 2002-02-26 Terumo Corp 止血剤
IT1317358B1 (it) 2000-08-31 2003-06-16 Fidia Advanced Biopolymers Srl Derivati cross-linkati dell'acido ialuronico.
US6364519B1 (en) * 2000-09-26 2002-04-02 Smith & Nephew, Inc. Bone cement system
US6458380B1 (en) 2000-11-09 2002-10-01 Richard Leaderman Dressing and preparation delivery system
US6635272B2 (en) 2000-11-09 2003-10-21 Richard N. Leaderman Wound dressing and drug delivery system
US20030009194A1 (en) * 2000-12-07 2003-01-09 Saker Mark B. Tissue tract sealing device
US7041868B2 (en) 2000-12-29 2006-05-09 Kimberly-Clark Worldwide, Inc. Bioabsorbable wound dressing
US6733774B2 (en) * 2001-01-25 2004-05-11 Nycomed Pharma As Carrier with solid fibrinogen and solid thrombin
US20020164322A1 (en) 2001-01-25 2002-11-07 Alfred Schaufler Suspension comprising fibrinogen, thrombin and alcohol, a method for preparing such a suspension, a method for coating a carrier with such a suspension, a method of drying a coating of a carrier, and a coated collagen sponge
US7052713B2 (en) 2001-02-13 2006-05-30 Nycomed Pharma As Carrier with solid fibrinogen and solid thrombin
US8187625B2 (en) * 2001-03-12 2012-05-29 Boston Scientific Scimed, Inc. Cross-linked gelatin composition comprising a wetting agent
US6685745B2 (en) 2001-05-15 2004-02-03 Scimed Life Systems, Inc. Delivering an agent to a patient's body
BR0102637A (pt) 2001-05-17 2003-02-25 Johnson & Johnson Ind Com Curativo adesivo
US7371403B2 (en) 2002-06-14 2008-05-13 Providence Health System-Oregon Wound dressing and method for controlling severe, life-threatening bleeding
JP4668510B2 (ja) * 2001-09-29 2011-04-13 持田製薬株式会社 可撓性容器入り局所止血用医薬組成物
WO2003055531A2 (en) * 2001-12-21 2003-07-10 Ferrosan A/S A hemostatic kit, a method of preparing a hemostatic agent and a method of promoting hemostasis
US7923431B2 (en) 2001-12-21 2011-04-12 Ferrosan Medical Devices A/S Haemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostatis
US20060189516A1 (en) 2002-02-19 2006-08-24 Industrial Technology Research Institute Method for producing cross-linked hyaluronic acid-protein bio-composites
US7427607B2 (en) 2002-02-20 2008-09-23 Next21 K.K. Drug administration method
JP4489437B2 (ja) 2002-02-21 2010-06-23 エンセル，インコーポレイテッド 表面コーティングとしての固定化生物活性ヒドロゲルマトリックス
US20050137512A1 (en) * 2003-12-23 2005-06-23 Campbell Todd D. Wound dressing and method for controlling severe, life-threatening bleeding
US20040101546A1 (en) * 2002-11-26 2004-05-27 Gorman Anne Jessica Hemostatic wound dressing containing aldehyde-modified polysaccharide and hemostatic agents
US20040120993A1 (en) * 2002-12-20 2004-06-24 Guanghui Zhang Hemostatic wound dressing and fabric and methods of making and using same
US7713551B2 (en) * 2002-09-11 2010-05-11 Elan Pharma International Ltd. Gel stabilized nanoparticulate active agent compositions
GB2393120A (en) 2002-09-18 2004-03-24 Johnson & Johnson Medical Ltd Compositions for wound treatment
US20040079763A1 (en) * 2002-10-29 2004-04-29 Powell Cindy Hagood Duplex storage pouch
US7112713B2 (en) 2003-03-12 2006-09-26 Gelsus Research And Consulting, Inc. Dressing based on the Teorell-Meyer gradient
US7129210B2 (en) * 2003-07-23 2006-10-31 Covalent Medical, Inc. Tissue adhesive sealant
US7109163B2 (en) 2004-01-30 2006-09-19 Ethicon, Inc. Hemostatic compositions and devices
US20050218541A1 (en) 2004-04-02 2005-10-06 Peng Henry T Method of producing interpenetrating polymer network
US20050245905A1 (en) 2004-04-30 2005-11-03 Schmidt Steven P Local drug-delivery system
GB2414021A (en) 2004-05-10 2005-11-16 Johnson & Johnson Medical Ltd Absorbable haemostatic materials
US7968085B2 (en) * 2004-07-05 2011-06-28 Ascendis Pharma A/S Hydrogel formulations
CN101001649B (zh) * 2004-07-09 2011-08-31 弗罗桑医疗设备公司 包括透明质酸的止血组合物及其制备方法
JP5047797B2 (ja) * 2004-09-30 2012-10-10 コヴァロン・テクノロジーズ・インコーポレーテッド 非接着性の弾性ゼラチンマトリックス
US9114194B2 (en) 2006-05-12 2015-08-25 W. L. Gore & Associates, Inc. Immobilized biologically active entities having high biological activity following mechanical manipulation
US8496953B2 (en) 2006-05-12 2013-07-30 W. L. Gore & Associates, Inc. Immobilized biologically active entities having a high degree of biological activity following sterilization
US20080095830A1 (en) * 2006-10-20 2008-04-24 Van Holten Robert W Method for making a dressing
US20080311172A1 (en) 2007-04-25 2008-12-18 Schapira Jay N Programmed-release, nanostructured biological construct
US20090087569A1 (en) * 2007-09-27 2009-04-02 Fenchem Enterprises Ltd. Methods for Preparing Highly Stable Hyaluronic Acid

Also Published As

Publication number Publication date
RU2377022C9 (ru) 2010-08-10
CN1921896A (zh) 2007-02-28
US7923031B2 (en) 2011-04-12
DE602005022554D1 (de) 2010-09-09
CA2554994C (en) 2015-05-19
AR054637A1 (es) 2007-07-11
EP1713521A2 (de) 2006-10-25
JP2007519450A (ja) 2007-07-19
US20070160543A1 (en) 2007-07-12
CA2554994A1 (en) 2005-08-11
WO2005072700A2 (en) 2005-08-11
WO2005072700A3 (en) 2005-09-09
EP1713521B1 (de) 2010-07-28
RU2377022C2 (ru) 2009-12-27
CN1921896B (zh) 2010-11-24
RU2006131128A (ru) 2008-03-10

Similar Documents

Publication Publication Date Title
DE602005022554D1 (de) Hämostatische sprays und zusammensetzungen
EP1781098A4 (de) Antimikrobielle geräte und zusammensetzungen
ATE492272T1 (de) Therapeutische antimikrobielle zusammensetzungen und methoden
EP1940423A4 (de) Gewebe-engineering-verfahren und zusammensetzungen
HRP20161230T1 (hr) Aerosolizirani fluorokinoloni i njihova uporaba
EP1680535A4 (de) Galvanisierzusammensetzungen und galvanisierverfahren
ITMI20041252A1 (it) Composizioni perfluoroelastomeriche
EP1778778A4 (de) Metallorganische zusammensetzungen und beschichtungszusammensetzungen
DE602006013492D1 (de) Verfahren und zwischenprodukte
DE602005017635D1 (de) Harzzusammensetzung und formteil daraus
IL186779A (en) Preparations to encourage blood arrest and other physiological activities
FR19C1066I2 (fr) Compositions ophtalmologiques et leur utilisation
DE602006014147D1 (de) Aroma- und duftstoffzusammensetzung
ATE350450T1 (de) Waschmittelzusammensetzungen und komponenten davon
DE602005016838D1 (de) Antibakterielle und entzündungshemmende mundpflegezusammensetzung
DK1827412T3 (da) Sammensætninger til anvendelse i kirurgi
ZA200704295B (en) Arthrospira-based compositions and uses thereof
DE602006020061D1 (de) Mucin-glycoprotein und anwendung davon
EP1719409A4 (de) Insektizidzusammensetzung
EP1874348A4 (de) Immunomodulierende zusammensetzungen und ihre verwendungen
EP1890677A4 (de) Pharmazeutische zusammensetzungen und ihre verwendung
DE602005009200D1 (de) Quecksilberfreisetzende zusammensetzungen und herstellungsverfahren dafür
DE602004026277D1 (de) Elastomerzusammensetzung und haftklebstoffzusammensetzungen
DE602005027222D1 (de) Schaumbare zusammensetzung
DE602005023325D1 (de) Harzzusammensetzung und formkörper daraus

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties